| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0019 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |